Diagnos, Inc. (ADK.V)
0.41
0.00 (0.00%)
CAD |
TSXV |
Aug 25, 15:35
Diagnos Gross Profit Margin (Quarterly) : -2.24K% for March 31, 2026
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | -2.24K% |
| December 31, 2025 | -2.64K% |
| September 30, 2025 | -2.37K% |
| June 30, 2025 | -1.92K% |
| March 31, 2025 | -1.58K% |
| December 31, 2024 | -1.06K% |
| September 30, 2024 | -1.28K% |
| June 30, 2024 | -242.8% |
| March 31, 2024 | -519.3% |
| December 31, 2023 | -383.3% |
| September 30, 2023 | -755.0% |
| June 30, 2023 | -400.0% |
| March 31, 2023 | -185.5% |
| December 31, 2022 | -31.42% |
| September 30, 2022 | -31.33% |
| June 30, 2022 | -64.36% |
| March 31, 2022 | -25.58% |
| December 31, 2021 | -82.43% |
| September 30, 2021 | -182.8% |
| June 30, 2021 | -163.8% |
| March 31, 2021 | -201.6% |
| December 31, 2020 | -110.7% |
| September 30, 2020 | -28.07% |
| June 30, 2020 | -240.3% |
| March 31, 2020 | -159.1% |
| Date | Value |
|---|---|
| December 31, 2019 | -97.23% |
| September 30, 2019 | -114.1% |
| June 30, 2019 | -206.6% |
| March 31, 2019 | 43.14% |
| December 31, 2018 | 33.12% |
| September 30, 2018 | -119.3% |
| June 30, 2018 | 14.93% |
| March 31, 2018 | -385.9% |
| December 31, 2017 | 54.22% |
| September 30, 2017 | -9.47% |
| June 30, 2017 | -1.19K% |
| March 31, 2017 | -17.24% |
| December 31, 2016 | 75.34% |
| September 30, 2016 | -239.0% |
| June 30, 2016 | -147.6% |
| March 31, 2016 | -157.2% |
| December 31, 2015 | 14.94% |
| September 30, 2015 | 0.00% |
| June 30, 2015 | 92.50% |
| March 31, 2015 | -136.9% |
| December 31, 2014 | 13.09% |
| September 30, 2014 | -127.7% |
| June 30, 2014 | -136.8% |
| March 31, 2014 | 52.21% |
| December 31, 2013 | 61.97% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Evokai Creative Labs, Inc. | -- |
| Arch Biopartners, Inc. | -- |
| Avricore Health, Inc. | -28.89% |
| Kane Biotech, Inc. | -53.01% |
| CardioComm Solutions, Inc. | -120.4% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -29.66K% |
| Return on Assets | -173.1% |
| Return on Invested Capital | -201.2% |
| Profit Margin (Quarterly) | -7.54K% |
| Operating Margin (Quarterly) | -7.27K% |
| Return on Net Operating Assets | -1.57K% |